Updated:
Investment Fund for Health in Africa
Max Coppoolse's IFHA runs a dedicated sub-Saharan healthcare PE strategy from Amsterdam and Nairobi, targeting clinics, pharma and diagnostics.
Investment Fund for Health in Africa
Amsterdam-based IFHA launched in 2007 and closed its first fund in 2009 at EUR 57 million, raising a second vehicle that reached a EUR 130 million final close by 2014. The founding team, led by Managing Partner Max Coppoolse, designed the firm to invest exclusively in private healthcare businesses across sub-Saharan Africa, targeting enterprises that serve the region's rapidly urbanizing population and expanding chronic-disease burden. IFHA concentrates on growth equity across healthcare delivery, pharmaceuticals, medical devices and health-tech. Portfolio companies operate in Kenya, Nigeria, Tanzania, South Africa and Ghana. Confirmed investments include Nairobi Women's Hospital, one of Kenya's largest private gender-focused providers, and the Hygeia Group, a leading Nigerian hospital operator. The firm typically deploys between USD 5 million and USD 15 million per transaction through direct equity and structured instruments, maintaining active board-level governance in each holding. IFHA operates a lean structure from Amsterdam and Nairobi, coordinating a distributed team of investment and operating professionals across multiple African markets. In 2022 the firm closed investments into a Nigerian retail pharmacy chain and a Tanzanian diagnostic laboratory platform, signaling continued deployment across its target healthcare verticals (per IFHA, 2022). The firm's limited partner base includes development-finance institutions such as FMO and the African Development Bank alongside European family offices and institutional allocators seeking sub-Saharan healthcare exposure. Structurally IFHA blends a European fund domicile with local operating partners on the ground — a configuration designed to navigate capital-control regimes and currency risk while maintaining the governance standards institutional LPs require. Its post-investment model relies on seconded operating executives rather than passive monitoring, reflecting the capacity-building demands of African healthcare enterprises.
General information
Firm type
Private Equity
Year founded
2007
AUM
$100M - $250M (Altss estimate)
Location
Region
Europe
Country
Netherlands
City
Amsterdam
Corporate office
Amsterdam, Netherlands
Additional offices
Nairobi, Kenya
Principals
Max Coppoolse
Managing Partner
Sector focus
Frequently asked questions
What is IFHA's investment mandate in terms of sector and geography?
IFHA invests exclusively in private healthcare businesses across sub-Saharan Africa. The firm targets healthcare delivery, pharmaceuticals, medical devices and health-tech across markets including Kenya, Nigeria, Tanzania, South Africa and Ghana. It does not invest outside the healthcare sector or outside sub-Saharan Africa.
Who makes investment decisions at IFHA?
Managing Partner Max Coppoolse, one of the firm's co-founders, leads the investment committee alongside senior partners based in Amsterdam and Nairobi. The firm maintains a flat decision-making structure designed for the small-to-mid-cap deal size it typically pursues.
Does IFHA invest in early-stage companies or only mature businesses?
IFHA pursues growth equity, targeting established private healthcare companies that require expansion capital rather than seed or venture-stage risk. The typical investment falls between USD 5 million and USD 15 million per transaction, aimed at companies with proven revenue models and unit-level profitability.
How is IFHA structured relative to a standard family office or a large cap fund?
IFHA is a dedicated private equity fund manager with a European-domiciled fund structure and on-the-ground operating partners in Nairobi. This combination allows it to meet the governance and reporting standards institutional limited partners require while navigating local currency, regulatory and operational realities in its target African markets.
What types of limited partners back IFHA?
The firm's investor base mixes development-finance institutions — such as FMO, the Dutch development bank, and the African Development Bank — with European family offices and institutional allocators. No single LP family or wealth origin dominates the fund.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: